Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts’ Top Healthcare Picks: Coya Therapeutics, Inc. (COYA), BioNTech SE (BNTX)

Tipranks - Sat Apr 11, 7:54AM CDT

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Coya Therapeutics, Inc. (COYA) and BioNTech SE (BNTX) with bullish sentiments.

Easter Sale - 70% Off TipRanks

Coya Therapeutics, Inc. (COYA)

In a report released today, Chad Messer from Lake Street maintained a Buy rating on Coya Therapeutics, Inc., with a price target of $17.00. The company’s shares closed last Thursday at $4.53.

According to TipRanks.com, Messer is a 1-star analyst with an average return of -0.7% and a 36.5% success rate. Messer covers the Healthcare sector, focusing on stocks such as OS Therapies Incorporated, Monopar Therapeutics Inc, and Bolt Biotherapeutics. ;'>

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Coya Therapeutics, Inc. with a $16.25 average price target.

See today’s best-performing stocks on TipRanks >>

BioNTech SE (BNTX)

Morgan Stanley analyst Terence Flynn maintained a Buy rating on BioNTech SE today and set a price target of $126.00. The company’s shares closed last Thursday at $91.98.

According to TipRanks.com, Flynn is a 5-star analyst with an average return of 9.8% and a 56.2% success rate. Flynn covers the Healthcare sector, focusing on stocks such as Structure Therapeutics, Inc. Sponsored ADR, Arvinas Holding Company, and Vertex Pharmaceuticals. ;'>

BioNTech SE has an analyst consensus of Strong Buy, with a price target consensus of $137.06, a 50.0% upside from current levels. In a report issued on March 31, H.C. Wainwright also reiterated a Buy rating on the stock with a $130.00 price target.

Read More on COYA:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.